We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$27M
Cap. Flow
-$19.1M
Cap. Flow %
-7.21%
Top 10 Hldgs %
60.48%
Holding
196
New
11
Increased
11
Reduced
19
Closed
23

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$6.67M
2
CSX icon
CSX Corp
CSX
+$2.11M
3
CLMT icon
Calumet Specialty Products
CLMT
+$1.85M
4
SNY icon
Sanofi
SNY
+$1.58M
5
ARDX icon
Ardelyx
ARDX
+$1.44M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$4.51M
2
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$3.08M
3
GLHAW
Glass Houses Acquisition Corp. Warrant
GLHAW
+$2.88M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.74M
5
PFE icon
Pfizer
PFE
+$2.35M

Sector Composition

Rank Sector Weight
1 Materials 29.69%
2 Healthcare 28.82%
3 Financials 9.61%
4 Miscellaneous 8.4%
5 Consumer Staples 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLMT icon
1
Calumet Specialty Products
CLMT
$4.2B
$74.9M 28.32%
4,440,000
+115,000
+3% +$1.85M
APO icon
2
Apollo Global Management
APO
$79.7B
$14.4M 5.42%
225,000
– –
MDLZ icon
3
Mondelez International
MDLZ
$79.6B
$14M 5.29%
14,000
– –
FBRT
4
Franklin BSP Realty Trust
FBRT
$703M
$11.1M 4.19%
859,047
– –
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.19T
$9.96M 3.76%
112,220
– –
DCGO icon
6
DocGo
DCGO
$39.3M
$9.9M 3.74%
1,400,000
– –
LGND icon
7
Ligand Pharmaceuticals
LGND
$5.59B
$7.68M 2.9%
115,000
-69,345
-38% -$4.51M
FTAI icon
8
FTAI Aviation
FTAI
$20B
$7.28M 2.75%
425,000
– –
MITAW
9
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$5.69M 2.15%
495,000
– –
AGAC.WS
10
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$5.18M 1.96%
450,750
– –
MDWT
11
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$4.97M 1.88%
390,241
– –
PFE icon
12
Pfizer
PFE
$159B
$4.84M 1.83%
94,500
-49,000
-34% -$2.35M
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.61M 1.74%
40,490
-3,000
-7% -$249K
OABI icon
14
OmniAb
OABI
$650M
$4.58M 1.73%
+1,270,939
New +$6.67M
JNJ icon
15
Johnson & Johnson
JNJ
$646B
$4.38M 1.66%
24,800
– –
ARDX icon
16
Ardelyx
ARDX
$984M
$4.28M 1.62%
1,500,000
+850,000
+131% +$1.44M
VKTX icon
17
Viking Therapeutics
VKTX
$3.75B
$3.59M 1.36%
381,621
+79,818
+26% +$356K
JAZZ icon
18
Jazz Pharmaceuticals
JAZZ
$15.9B
$3.57M 1.35%
22,411
– –
CTIC
19
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.41M 1.29%
566,687
– –
KW
20
DELISTED
Kennedy-Wilson Holdings
KW
$2.75M 1.04%
175,000
– –
JPM icon
21
JPMorgan Chase
JPM
$951B
$2.73M 1.03%
20,385
– –
MRK icon
22
Merck
MRK
$366B
$2.72M 1.03%
24,500
– –
SNY icon
23
Sanofi
SNY
$107B
$2.71M 1.02%
56,000
+36,000
+180% +$1.58M
XENE icon
24
Xenon Pharmaceuticals
XENE
$5.81B
$2.35M 0.89%
59,500
– –
MDGL icon
25
Madrigal Pharmaceuticals
MDGL
$12.3B
$2.32M 0.88%
8,000
+7,000
+700% +$685K
1
2 3 4 5

Similar funds

GFL
Granite FO LLC Bedford, New Hampshire $189M AUM 56.18% 1-Year Est. Return
SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FSBI
Fearless Solutions (Best Invest) San Antonio, Texas $189M AUM 32.69% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM

David M. Knott Jr's Q4 2022 Portfolio in Review

As of Q4 2022, David M. Knott Jr held 196 positions worth $265M, up 11% from $238M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

David M. Knott Jr withdrew a net $19.1M in Q4 2022, closing 23 positions and reducing 19 holdings. Its most notable exit was Eiger BioPharmaceuticals, Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Materials at 30% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, David M. Knott Jr opened a new position in OmniAb worth $4.58M.

  • David M. Knott Jr's largest Q4 2022 buy was OmniAb: 1,270,939 shares worth $4.58M.
  • David M. Knott Jr added most to Calumet Specialty Products in Q4 2022, an estimated $1.85M increase.
  • David M. Knott Jr's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $4.51M.
  • David M. Knott Jr fully exited Eiger BioPharmaceuticals, Inc. in Q4 2022, selling an estimated $3.08M.
  • David M. Knott Jr's ten largest holdings make up 60% of its $265M portfolio in Q4 2022.
  • David M. Knott Jr opened 11 new positions and closed 23 in Q4 2022.
  • David M. Knott Jr's portfolio value rose 11% quarter-over-quarter to $265M.

Based on David M. Knott Jr's 13F filing for Q4 2022, filed 13 Feb 2023.